Largest Australian (ASX) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CSL CSL	AU$274.30	-3.9%	5.8%	AU$132.8b	AU$327.80	PE32.7x	E13.0%	1.5%
TLX Telix Pharmaceuticals	AU$22.96	-0.09%	151.2%	AU$7.7b	AU$25.62	PE156.2x	E38.3%	n/a
CU6 Clarity Pharmaceuticals	AU$6.06	-14.2%	362.6%	AU$1.9b	AU$8.89	PS168.6x	E68.2%	n/a
MSB Mesoblast	AU$1.58	3.3%	298.7%	AU$1.8b	AU$1.46	PS198x	E61.5%	n/a
NEU Neuren Pharmaceuticals	AU$13.69	-17.2%	-9.4%	AU$1.7b	AU$26.21	PE14.9x	E-9.9%	n/a
PYC PYC Therapeutics	AU$1.90	-2.6%	146.8%	AU$835.2m	AU$3.30	PS40.2x	E34.7%	n/a
OPT Opthea	AU$0.66	-13.2%	78.4%	AU$812.5m	n/a	PS2017.5x	E61.9%	n/a
CUV Clinuvel Pharmaceuticals	AU$13.40	-2.1%	-18.0%	AU$669.3m	AU$28.29	PE18.8x	E26.2%	0.4%
BOT Botanix Pharmaceuticals	AU$0.32	-1.6%	103.2%	AU$572.5m	n/a	PS276.6x	E99.4%	n/a
IMM Immutep	AU$0.30	-1.6%	7.0%	AU$443.6m	n/a	PS115.5x	E38.6%	n/a
MYX Mayne Pharma Group	AU$4.45	-9.0%	-7.1%	AU$361.1m	AU$6.09	PB0.8x	E110.0%	n/a
IMU Imugene	AU$0.04	-13.0%	-52.4%	AU$297.5m	n/a	PS59.9x	E53.4%	n/a
RAC Race Oncology	AU$1.36	-7.2%	49.5%	AU$231.8m	AU$3.67	PS57.9x	E0.1%	n/a
ARX Aroa Biosurgery	AU$0.64	-2.3%	-5.2%	AU$219.0m	n/a	PS3.5x	E56.3%	n/a
ALA Arovella Therapeutics	AU$0.18	-7.5%	122.9%	AU$194.9m	n/a	PS99.9x	n/a	n/a
LTP LTR Pharma	AU$1.22	-12.9%	n/a	AU$187.6m	n/a	PS3829.2x	n/a	n/a
DXB Dimerix	AU$0.34	-14.1%	139.3%	AU$186.6m	n/a	PS319.9x	n/a	n/a
GSS Genetic Signatures	AU$0.70	-1.4%	55.6%	AU$158.8m	AU$1.10	PS11.5x	E98.6%	n/a
TRJ Trajan Group Holdings	AU$1.02	-12.1%	-17.1%	AU$155.3m	AU$1.40	PS1x	E99.2%	n/a
OCC Orthocell	AU$0.63	-6.0%	58.2%	AU$149.4m	n/a	PS28.1x	n/a	n/a
EZZ EZZ Life Science Holdings	AU$2.87	-4.3%	370.5%	AU$127.5m	AU$5.45	PE18.3x	E17.9%	1.0%
VLS Vita Life Sciences	AU$2.09	0%	25.9%	AU$117.7m	n/a	PE12.5x	n/a	4.3%
RCE Recce Pharmaceuticals	AU$0.46	-4.2%	2.2%	AU$106.7m	AU$2.46	PS21.2x	E-53.4%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.28	16.7%	-29.1%	AU$98.1m	n/a	PB4.1x	E8.8%	n/a